Develops enzymatic therapeutics for wound and burn care.
Dec 2025Revenue $17.0M/yrExpenses $42.2M/yr
No trendCash runway ≈ 3 months from Dec 2025
Figures by year
When will MediWound be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $17.0M and expenses $42.2M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $17.0M | $42.2M | −$25.3M |
| Dec 2024 | $20.2M | $39.6M | −$19.4M |
| Dec 2023 | $18.7M | $34.0M | −$15.3M |
| Dec 2022 | $26.5M | $34.8M | −$8.35M |
| Dec 2021 | $23.8M | $35.0M | −$11.2M |
| Dec 2020 | $21.8M | $30.6M | −$8.84M |
| Dec 2019 | $31.8M | $27.3M | $4.49M |
| Dec 2018 | $3.40M | $7.36M | −$3.96M |
| Dec 2017 | $2.50M | $16.2M | −$13.7M |
| Dec 2016 | $1.56M | $21.7M | −$20.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.